Weil Company Inc. Makes New $414,000 Investment in McKesson Corporation $MCK

Weil Company Inc. purchased a new stake in shares of McKesson Corporation (NYSE:MCK) during the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm purchased 536 shares of the company’s stock, valued at approximately $414,000.

Several other institutional investors have also recently made changes to their positions in the business. Norges Bank bought a new stake in McKesson during the 2nd quarter valued at approximately $1,346,661,000. Alliancebernstein L.P. grew its holdings in McKesson by 150.4% during the 2nd quarter. Alliancebernstein L.P. now owns 2,268,015 shares of the company’s stock valued at $1,661,956,000 after buying an additional 1,362,386 shares in the last quarter. Arrowstreet Capital Limited Partnership raised its position in shares of McKesson by 56.4% during the second quarter. Arrowstreet Capital Limited Partnership now owns 1,236,536 shares of the company’s stock valued at $906,109,000 after buying an additional 446,060 shares during the last quarter. DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main lifted its holdings in shares of McKesson by 45.6% in the second quarter. DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main now owns 833,780 shares of the company’s stock worth $610,977,000 after buying an additional 261,296 shares in the last quarter. Finally, Acadian Asset Management LLC boosted its position in shares of McKesson by 68.0% during the second quarter. Acadian Asset Management LLC now owns 636,596 shares of the company’s stock worth $466,441,000 after acquiring an additional 257,670 shares during the last quarter. Hedge funds and other institutional investors own 85.07% of the company’s stock.

Analyst Ratings Changes

MCK has been the topic of a number of research reports. Wells Fargo & Company lifted their price target on shares of McKesson from $914.00 to $925.00 and gave the company an “equal weight” rating in a report on Thursday, February 5th. Barclays began coverage on McKesson in a research report on Monday, December 8th. They set an “overweight” rating and a $960.00 price objective for the company. Robert W. Baird set a $968.00 target price on McKesson in a research report on Wednesday, January 14th. UBS Group raised their price target on McKesson from $920.00 to $980.00 and gave the company a “buy” rating in a report on Thursday, November 6th. Finally, Mizuho lifted their price objective on McKesson from $880.00 to $885.00 and gave the stock a “neutral” rating in a research note on Thursday, February 5th. One research analyst has rated the stock with a Strong Buy rating, twelve have assigned a Buy rating and four have issued a Hold rating to the company’s stock. According to data from MarketBeat, McKesson has an average rating of “Moderate Buy” and an average price target of $937.07.

Insider Buying and Selling at McKesson

In other McKesson news, EVP Thomas L. Rodgers sold 276 shares of the business’s stock in a transaction on Monday, January 5th. The shares were sold at an average price of $816.18, for a total transaction of $225,265.68. Following the transaction, the executive vice president owned 2,268 shares in the company, valued at $1,851,096.24. The trade was a 10.85% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, CAO Napoleon B. Rutledge, Jr. sold 328 shares of the stock in a transaction on Friday, February 6th. The shares were sold at an average price of $955.00, for a total transaction of $313,240.00. The SEC filing for this sale provides additional information. 0.08% of the stock is owned by insiders.

McKesson Trading Up 1.9%

Shares of NYSE:MCK opened at $933.75 on Friday. The company has a market cap of $114.37 billion, a price-to-earnings ratio of 26.86, a PEG ratio of 1.50 and a beta of 0.40. McKesson Corporation has a 12 month low of $585.22 and a 12 month high of $971.93. The company has a 50-day moving average price of $840.13 and a 200 day moving average price of $788.06.

McKesson (NYSE:MCK) last issued its quarterly earnings data on Wednesday, February 4th. The company reported $9.34 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $9.19 by $0.15. The business had revenue of $106.16 billion for the quarter, compared to the consensus estimate of $105.98 billion. McKesson had a negative return on equity of 338.97% and a net margin of 1.09%.The company’s quarterly revenue was up 11.4% compared to the same quarter last year. During the same period in the prior year, the business posted $8.03 earnings per share. McKesson has set its FY 2026 guidance at 38.800-39.200 EPS. As a group, equities analysts forecast that McKesson Corporation will post 32.77 EPS for the current year.

McKesson Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, April 1st. Investors of record on Monday, March 2nd will be given a $0.82 dividend. The ex-dividend date is Monday, March 2nd. This represents a $3.28 dividend on an annualized basis and a yield of 0.4%. McKesson’s dividend payout ratio (DPR) is currently 9.43%.

McKesson Profile

McKesson Corporation (NYSE: MCK) is a global healthcare services and distribution company that supplies pharmaceuticals, medical-surgical products and health care technology solutions. Founded in 1833 and headquartered in Irving, Texas, McKesson operates across the drug distribution and healthcare services value chain, connecting manufacturers, pharmacies, hospitals and health systems to help manage the movement of medicines and clinical supplies.

The company’s core activities include pharmaceutical wholesale distribution and logistics, specialty pharmacy services, and the provision of medical-surgical supplies to acute and non-acute care providers.